交易 Lumos Pharma, Inc. - LUMO CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.16 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 27, 2024 | 2.79 | 0.01 | 0.36% | 2.78 | 2.84 | 2.77 |
Mar 26, 2024 | 2.82 | 0.07 | 2.55% | 2.75 | 2.86 | 2.75 |
Mar 25, 2024 | 2.76 | 0.02 | 0.73% | 2.74 | 2.76 | 2.69 |
Mar 22, 2024 | 2.69 | -0.06 | -2.18% | 2.75 | 2.75 | 2.63 |
Mar 21, 2024 | 2.88 | 0.07 | 2.49% | 2.81 | 2.89 | 2.73 |
Mar 20, 2024 | 2.80 | 0.22 | 8.53% | 2.58 | 2.85 | 2.58 |
Mar 19, 2024 | 2.64 | 0.08 | 3.13% | 2.56 | 2.78 | 2.55 |
Mar 18, 2024 | 2.62 | -0.02 | -0.76% | 2.64 | 2.73 | 2.59 |
Mar 15, 2024 | 2.68 | 0.05 | 1.90% | 2.63 | 2.72 | 2.62 |
Mar 14, 2024 | 2.58 | -0.37 | -12.54% | 2.95 | 2.95 | 2.51 |
Mar 13, 2024 | 2.95 | -0.02 | -0.67% | 2.97 | 2.97 | 2.95 |
Mar 12, 2024 | 3.00 | 0.04 | 1.35% | 2.96 | 3.03 | 2.96 |
Mar 11, 2024 | 3.02 | 0.08 | 2.72% | 2.94 | 3.02 | 2.90 |
Mar 8, 2024 | 3.02 | 0.05 | 1.68% | 2.97 | 3.05 | 2.91 |
Mar 7, 2024 | 2.99 | -0.02 | -0.66% | 3.01 | 3.01 | 2.94 |
Mar 6, 2024 | 2.99 | 0.04 | 1.36% | 2.95 | 3.00 | 2.94 |
Mar 5, 2024 | 3.02 | 0.04 | 1.34% | 2.98 | 3.03 | 2.98 |
Mar 4, 2024 | 2.96 | 0.02 | 0.68% | 2.94 | 3.01 | 2.93 |
Mar 1, 2024 | 2.98 | 0.07 | 2.41% | 2.91 | 3.01 | 2.89 |
Feb 29, 2024 | 2.91 | 0.03 | 1.04% | 2.88 | 3.01 | 2.87 |
Lumos Pharma, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Wednesday, May 1, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q1 2024 Lumos Pharma Inc Earnings Release Q1 2024 Lumos Pharma Inc Earnings ReleaseForecast(預報) -返回 - |
Thursday, May 9, 2024 | ||
時間 (UTC) 14:00 | 國家 US
| 事件 Lumos Pharma Inc Annual Shareholders Meeting Lumos Pharma Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 1.523 | 0.23 | 0.168 | 0.936 | 12.474 |
收入 | 1.523 | 0.23 | 0.168 | 0.936 | 12.474 |
總營業費用 | 33.563 | 31.577 | 26.471 | 46.07 | 74.912 |
銷售/一般/行政費用,總計 | 15.706 | 15.331 | 17.265 | 20.565 | 28.418 |
研究與開發 | 17.857 | 16.246 | 9.206 | 19.905 | 45.194 |
異常費用(收入) | 5.6 | 1.3 | |||
營業收入 | -32.04 | -31.347 | -26.303 | -45.134 | -62.438 |
利息收入(費用),非經營淨值 | 0.874 | 0.012 | 0.2 | 2.176 | 1.977 |
其他,淨值 | 0.091 | 0.269 | 6.467 | -0.019 | -0.102 |
稅前淨收入 | -31.075 | -31.066 | -19.636 | -42.977 | -60.563 |
稅後淨收入 | -31.062 | -30.43 | -5.663 | -42.989 | -53.595 |
未計算非常項目前的淨收益 | -31.062 | -30.43 | -5.663 | -42.989 | -53.595 |
淨收入 | -31.062 | -30.43 | -5.663 | -42.989 | -53.595 |
普通股股東可獲收益 (不含非經常性項目) | -31.062 | -30.43 | -6.314 | -42.989 | -53.595 |
普通股股東可獲收益 (含非經常性項目) | -31.062 | -30.43 | -6.314 | -42.989 | -53.595 |
攤薄淨收入 | -31.062 | -30.43 | -6.314 | -42.989 | -53.595 |
攤薄後加權平均股 | 8.37382 | 8.33452 | 6.77793 | 4.14383 | 4.13232 |
扣除特別項目的每股攤薄盈利 | -3.70942 | -3.65108 | -0.93155 | -10.3742 | -12.9697 |
每股正常攤薄盈利 | -3.70942 | -3.65108 | -0.93155 | -9.44074 | -12.7652 |
Total Adjustments to Net Income | 0 | -0.651 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0.527 | 0.691 | 0.512 | 0.497 | 0.403 |
收入 | 0.527 | 0.691 | 0.512 | 0.497 | 0.403 |
總營業費用 | 10.17 | 8.726 | 9.347 | 8.047 | 8.327 |
銷售/一般/行政費用,總計 | 4.146 | 4.357 | 4.485 | 3.918 | 3.682 |
研究與開發 | 6.024 | 4.369 | 4.862 | 4.129 | 4.645 |
營業收入 | -9.643 | -8.035 | -8.835 | -7.55 | -7.924 |
利息收入(費用),非經營淨值 | 0.559 | 0.57 | 0.503 | 0.292 | 0.074 |
其他,淨值 | 0.124 | 0.119 | 0.072 | 0.007 | 0.006 |
稅前淨收入 | -8.96 | -7.346 | -8.26 | -7.251 | -7.844 |
稅後淨收入 | -8.931 | -7.346 | -8.247 | -7.251 | -7.844 |
未計算非常項目前的淨收益 | -8.931 | -7.346 | -8.247 | -7.251 | -7.844 |
淨收入 | -8.931 | -7.346 | -8.247 | -7.251 | -7.844 |
Total Adjustments to Net Income | |||||
普通股股東可獲收益 (不含非經常性項目) | -8.931 | -7.346 | -8.247 | -7.251 | -7.844 |
普通股股東可獲收益 (含非經常性項目) | -8.931 | -7.346 | -8.247 | -7.251 | -7.844 |
攤薄淨收入 | -8.931 | -7.346 | -8.247 | -7.251 | -7.844 |
攤薄後加權平均股 | 8.1646 | 8.23994 | 8.38094 | 8.38803 | 8.36645 |
扣除特別項目的每股攤薄盈利 | -1.09387 | -0.89151 | -0.98402 | -0.86445 | -0.93755 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -1.09387 | -0.89151 | -0.98402 | -0.86445 | -0.93755 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 72.009 | 99.677 | 128.449 | 94.419 | 127.072 |
現金和短期投資 | 67.359 | 94.809 | 98.679 | 90.549 | 120.738 |
現金等價物 | 56.007 | 94.809 | 98.679 | 90.549 | 120.738 |
短期投資 | 11.352 | ||||
應收賬款總額,淨額 | 0.223 | 0.128 | 26.264 | 0.824 | 0.798 |
預付的費用 | 4.427 | 4.74 | 3.506 | 3.046 | 5.536 |
總資産 | 72.292 | 100.312 | 129.033 | 96.787 | 130.939 |
物業/廠房/設備,總計 - 淨額 | 0.283 | 0.635 | 0.584 | 2.368 | 3.727 |
物業/廠房/設備,總計 - 總額 | 10.158 | 10.712 | |||
累計折舊,總計 | -7.79 | -6.985 | |||
流動負債總額 | 6.708 | 5.13 | 6.461 | 11.827 | 8.847 |
應付賬款 | 0.275 | 0.612 | 0.244 | 0.475 | 0.555 |
預提費用 | 6.433 | 4.518 | 6.217 | 11.298 | 8.139 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.043 | 0.061 | |||
其他流動負債,總計 | 0.011 | 0.092 | |||
負債總額 | 12.708 | 11.335 | 12.461 | 17.909 | 15.796 |
長期債務總額 | 0 | 0 | 0 | 0 | 0.043 |
長期債務 | 0 | 0.043 | |||
其他負債,總計 | 6 | 6.205 | 6 | 6.082 | 6.906 |
股權 | 59.584 | 88.977 | 116.572 | 78.878 | 115.143 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
普通股 | 0.082 | 0.083 | 0.083 | 0.374 | 0.373 |
額外實收資本 | 187.164 | 185.429 | 182.48 | 413.959 | 407.199 |
留存收益(累計赤字) | -127.483 | -96.421 | -65.991 | -334.001 | -291.012 |
Treasury Stock - Common | -0.17 | -0.114 | -1.454 | -1.417 | |
總負債和股東權益 | 72.292 | 100.312 | 129.033 | 96.787 | 130.939 |
已發行普通股總數 | 8.26797 | 8.35739 | 8.30527 | 4.14719 | 4.13898 |
應收票據 - 長期 | 0 | 0.14 | |||
Preferred Stock - Non Redeemable, Net | 0 | ||||
其他權益,總計 | -0.009 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 47.447 | 55.983 | 63.253 | 72.009 | 78.832 |
現金和短期投資 | 42.694 | 50.851 | 57.983 | 67.359 | 73.666 |
現金等價物 | 35.557 | 37.862 | 44.038 | 56.007 | 73.666 |
應收賬款總額,淨額 | 0.172 | 0.233 | 0.2 | 0.223 | 0.168 |
預付的費用 | 4.581 | 4.899 | 5.07 | 4.427 | 4.998 |
總資産 | 47.751 | 56.373 | 63.725 | 72.292 | 79.209 |
物業/廠房/設備,總計 - 淨額 | 0.304 | 0.39 | 0.472 | 0.283 | 0.377 |
流動負債總額 | 6.116 | 6.545 | 5.017 | 6.708 | 5.483 |
應付賬款 | 0.488 | 0.279 | 0.837 | 0.275 | 0.71 |
預提費用 | 5.628 | 6.266 | 4.18 | 6.433 | 4.773 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 12.259 | 12.712 | 11.206 | 12.708 | 11.502 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 6.143 | 6.167 | 6.189 | 6 | 6.019 |
股權 | 35.492 | 43.661 | 52.519 | 59.584 | 67.707 |
Redeemable Preferred Stock | |||||
普通股 | 0.079 | 0.08 | 0.081 | 0.082 | 0.083 |
額外實收資本 | 187.673 | 187.539 | 187.446 | 187.164 | 187.03 |
留存收益(累計赤字) | -152.06 | -143.76 | -134.829 | -127.483 | -119.236 |
Treasury Stock - Common | -0.196 | -0.187 | -0.174 | -0.17 | -0.17 |
總負債和股東權益 | 47.751 | 56.373 | 63.725 | 72.292 | 79.209 |
已發行普通股總數 | 7.91458 | 8.04135 | 8.1833 | 8.26797 | 8.37527 |
Preferred Stock - Non Redeemable, Net | |||||
短期投資 | 7.137 | 12.989 | 13.945 | 11.352 | |
其他權益,總計 | -0.004 | -0.011 | -0.005 | -0.009 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -31.062 | -30.43 | -5.663 | -42.989 | -53.595 |
經營活動産生的現金 | -26.623 | -29.648 | -22.997 | -30.207 | -37.939 |
經營活動産生的現金 | 0.049 | 0.273 | 0.584 | 1.645 | 1.145 |
非現金物品 | 2.294 | 2.823 | -4.8 | 6.542 | 17.222 |
Cash Taxes Paid | 0 | -4.473 | 0.015 | 0.025 | |
已付現金利息 | 0 | 0.008 | 0.004 | 0.008 | |
營運資金的變化 | 2.096 | -2.314 | -3.618 | 4.595 | -2.711 |
投資活動産生的現金 | -11.358 | 25.97 | 116.649 | 0.077 | 0.117 |
資本支出 | -0.021 | -0.03 | -0.03 | 0 | -0.007 |
其他投資現金流量項目,總計 | -11.337 | 26 | 116.679 | 0.077 | 0.124 |
融資活動産生的現金 | -0.821 | -0.192 | 0.075 | -0.059 | -0.148 |
融資現金流項目 | -0.056 | -0.114 | |||
股票的發行(報廢),淨額 | -0.765 | -0.078 | 0.102 | 0.002 | 0.019 |
債務的發行(退還),淨額 | 0 | -0.027 | -0.061 | -0.167 | |
現金淨變化 | -38.802 | -3.87 | 93.727 | -30.189 | -37.97 |
Deferred Taxes | 0 | -9.5 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -7.346 | -31.062 | -22.815 | -15.564 | -7.72 |
Cash From Operating Activities | -9.197 | -26.623 | -20.797 | -15.278 | -8.033 |
Cash From Operating Activities | 0.009 | 0.049 | 0.014 | 0.01 | 0.012 |
Deferred Taxes | |||||
Non-Cash Items | 0.45 | 2.294 | 1.733 | 1.14 | 0.565 |
Changes in Working Capital | -2.31 | 2.096 | 0.271 | -0.864 | -0.89 |
Cash From Investing Activities | -2.463 | -11.358 | 0 | 0 | 0 |
Other Investing Cash Flow Items, Total | -2.463 | -11.337 | 0 | 0 | 0 |
Cash From Financing Activities | -0.309 | -0.821 | -0.346 | -0.02 | -0.018 |
Financing Cash Flow Items | -0.004 | -0.056 | -0.056 | -0.037 | -0.005 |
Issuance (Retirement) of Stock, Net | -0.305 | -0.765 | -0.29 | 0.017 | -0.013 |
Net Change in Cash | -11.969 | -38.802 | -21.143 | -15.298 | -8.051 |
Capital Expenditures | -0.021 | ||||
Issuance (Retirement) of Debt, Net | |||||
Cash Taxes Paid | |||||
Cash Interest Paid |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
4200 Marathon Blvd.
Suite 200
AUSTIN
TEXAS 78756
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易